VEGFA and cancer: We also demonstrated the underlying mechanisms that cisplatin-induced HIF-1 pathways including “xCT and GCLM/GSH/cisplatin binding,” “MRP2 and P-gp/cisplatin efflux,” and “VEGF/cancer metastasis” were successfully inhibited by ACF in the combined nanoformulation.